Previously, several clinical trials using irinotecan have reported a signal of response in a subset of patients [17, 18]; however, these trials were conducted before the era of precision medicine, and thus the correlation between treatment response and tumor TOP1 expression was not evaluated. Here, TOP1 is linked to neoplasm.